Fortress Biotech, Inc. (FBIO) — Business segments and KPIs
Revenue by business segment and geography for Fortress Biotech, Inc., with year-over-year trends.
FY 2024
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| Qbrexza | 25.11M | 49.1% |
| Accutane | 19.41M | 37.9% |
| Amzeeq | 5.01M | 9.8% |
| Zilxi | 1.64M | 3.2% |